Phoenix Molecular Designs

Phoenix Molecular Designs is a biotechnology company that designs precise cancer therapies by targeting essential kinases. The company addresses the development of advanced breast cancer treatments by leveraging novel intellectual property and a team with global problem-solving experience. Its drugs will specifically and accurately bind to proteins responsible for unchecked cancer growth and "unlock" these proteins to trigger cancer cell death, without affecting normal, healthy surrounding cells. The company's therapeutic focus is on one of the three most aggressive types of breast cancer: triple-negative breast cancer (TNBC).